Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

243.84
+0.25000.10%
Post-market: 247.203.36+1.38%18:52 EDT
Volume:569.60K
Turnover:139.47M
Market Cap:15.83B
PE:16.67
High:247.31
Open:246.59
Low:243.57
Close:243.59
52wk High:266.38
52wk Low:125.79
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.88
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.30
PE(LYR):-41.75

Loading ...

Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]